PRB

From 2015 to 2019, the African-led consortium developed innovative research methods and uncovered new evidence about the practice and how it is changing—focusing on families and communities, and health and legal systems—in eight countries: Burkina Faso, Egypt, Ethiopia, Kenya, Nigeria, Senegal, Somalia, and Sudan.

From 2015 to 2019, the African-led consortium developed innovative research methods and uncovered new evidence about the practice and how it is changing—focusing on families and communities, and health and legal systems—in eight countries: Burkina Faso, Egypt, Ethiopia, Kenya, Nigeria, Senegal, Somalia, and Sudan.

The video highlights how the four P’s—product, price, place, and promotion—can be used to design a high-quality FGM/C campaign.

This site offers a clear understanding of the health effects of FGM/C to provide direction for future investment by donors, highlight important knowledge gaps for further research, help medical professionals identify and manage complications, and strengthen advocates’ messages.

This web feature offers a clear understanding of the health effects of FGM/C to provide direction for future investment by donors, highlight important knowledge gaps for further research, help medical professionals identify and manage complications, and strengthen advocates’ messages.

PRB has developed a web feature, “Understanding the Impact of Medicalisation on Female Genital Mutilation/Cutting,” that outlines the best available information on medicalization.

PRB has prepared a set of three Evidence Briefs, summarizing the program’s findings on FGM/C and its relationship to HIV, fistula, and early/child marriage. The Evidence Briefs highlight what we know and still need to understand based on the program’s rigorous review of the existing research literature and analysis of data from recent national surveys in select sub-Saharan African countries.